AKT1 and neoplasm: Cancer cells’ greed for glucose inactivates effector T cells and DCs, whereas programmed cell death ligand-1 (PD-L1) expressed by tumor cells stimulates glycolysis and the Akt pathway in cancer cells, thereby helping maintain its proliferation (Jayavelu et al., 2022).